Q4 2018 Investor Presentation

Why Invest? - Driving Long-Term Shareholder Value لحا Market Dynamics Underpenetrated markets in sleep & COPD • Healthcare costs continue to increase • Focus on improving patient outcomes • Value-based . technology solutions Growth & Innovation Global leader in connected health for sleep and respiratory care • Long-term growth opportunities 5,500 + patents and designs - 7% of revenue invested in R&D Financial Results • Historical revenue and • profit growth Recurring revenue Operating excellence program Strong track record of capital deployment © 2018 ResMed | Q4 2018 Investor Presentation | 37 ResMed

View entire presentation